Stanca-Lucia Pandrea

Dr. Stanca-Lucia Pandrea

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2022 in Biology
Verified
Journal Article
Open access
PDF file
Dan-Alexandru TocDan-Alexandru Toc
Dan-Alexandru Toc
SPStanca-Lucia Pandrea
Stanca-Lucia Pandrea
Alexandru BotanAlexandru Botan
Alexandru Botan
RMRazvan Marian Mihaila
Razvan Marian Mihaila
CCCarmen Costache
Carmen Costache
LJLia Monica Junie
Lia Monica Junie
(1) Background: This paper aims to provide a description of non-faecalis non-faecium enterococci isolated from a tertiary care hospital in Romania and to briefly review the existing literature regarding the involvement of Enterococcus raffinosus, Enterococcus durans and Enterococcus avium in human infections and their antimicrobial resistance patterns; (2) Methods: We retrospectively analyzed all Enteroccocus species isolated from the “Prof. Dr. O. Fodor” Regional Institute of Gastroenterology and Hepatology from Cluj-Napoca during one year focusing on non-faecalis non-faecium Enterococci. A brief review of the literature was performed using case reports involving Enterococcus raffinosus, Enterococcus durans and Enterococcus avium; (3) Results: Only 58 out of 658 Enteroccocus isolates were non-faecalis non-faecium and met the inclusion criteria. These species were isolated more often (p < 0.05) from the surgical ward from mixed etiology infections with E. coli. In our review, we included 39 case reports involving E. raffinosus, E. durans and E. avium; (4) Conclusions: Isolation of non-faecalis non-faecium enterococci displays an emerging trend with crucial healthcare consequences. Based on the analysis of the case reports, E. avium seems to be involved more often in neurological infections, E. durans in endocarditis, while E. raffinosus displays a more heterogenous distribution.

28 December 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
ATAnamaria Tomșa
Anamaria Tomșa
A(Andreea-Liana Boț (Răchișan)
Andreea-Liana Boț (Răchișan)
SPStanca-Lucia Pandrea
Stanca-Lucia Pandrea
ABAndreea Benea
Andreea Benea
AUAna Uifălean
Ana Uifălean
LJLia Monica Junie
Lia Monica Junie
Gentamicin remains widely used in all age groups despite its well-documented nephrotoxicity; however, no adjuvant therapies have been established to counteract this side effect. Our study aimed to experimentally determine whether curcumin and vitamin C have nephroprotective effects and whether certain reactive species could be used as markers of early gentamicin nephrotoxicity. Wistar adult male rats were evenly distributed into four groups: control, gentamicin, curcumin and gentamicin, vitamin C and gentamicin (gentamicin: 60 mg/kg/day, intraperitoneally, 7 days). We determined renal function (urea, creatinine), oxidative stress (malondialdehyde, nitric oxide, 3-nitrotyrosine, total oxidative stress), and antioxidant and anti-inflammatory status (thiols, total antioxidant capacity, interleukin-10). Nephrotoxicity was successfully induced, as shown by the elevated creatinine levels in the gentamicin group. In contrast, supplementation with curcumin and vitamin C prevented an increase in urea levels while decreasing total oxidative stress levels compared to the gentamicin group. Moreover, vitamin C and curcumin distinctively modulate the levels of nitric oxide and malondialdehyde. Histological analysis showed more discrete lesions in rats that received vitamin C compared to the curcumin group.

31 May 2020 in Coatings
Verified
Journal Article
Open access
PDF file
IVIonescu Corina Violeta
Ionescu Corina Violeta
ADAda Gabriela Delean
Ada Gabriela Delean
AMAdriana Muresan
Adriana Muresan
MVMadalina Ana Valeanu
Madalina Ana Valeanu
A(Amalia Mazilu (Moldovan)
Amalia Mazilu (Moldovan)
SPStanca-Lucia Pandrea
Stanca-Lucia Pandrea
Among esthetic procedures, teeth whitening is a common and often used treatment for patients who seek good teeth appearance. We developed an experimental green tea extract and an experimental green tea gel for enamel restoring treatment after bleaching. We also tested the antibacterial and antifungal effect of the experimental extract against specific endodontic and cariogenic microorganisms. The green tea extract antibacterial action was determined by the disk-diffusion method using Peptostreptococcus anaerobius (ATCC27337), Corynebacterium xerosis (ATCC 373), Streptococcus mutans (ATCC 25175) and Candida albicans (ATCC 10231) strains. Enamel microstructure was investigated by SEM analysis, and surface details were revealed by AFM. The inhibition zones around the wells showed evident antimicrobial activity of the experimental extract. In the presence of Candida albicans (ATCC 10231), the extract showed no antifungal activity. The enamel’s surface roughness and hydroxyapatite prism aspects were the parameters followed throughout the study. The experimental green tea extract is efficient against some microorganisms commonly found in the oral cavity. However, the studied extract had no antifungal effect. The results show that after bleaching with the experimental gel, we obtained the best surface parameters, similar to healthy enamel.

23 October 2025 in Life
Verified
Journal Article
Open access
PDF file
APAida C Puia
Aida C Puia
SPStanca-Lucia Pandrea
Stanca-Lucia Pandrea
JCJeanine Cruceru
Jeanine Cruceru
CPCosmin Ion Puia
Cosmin Ion Puia
VCVeronica Chedea
Veronica Chedea
Raluca Maria PopRaluca Maria Pop
Raluca Maria Pop
Mushrooms have long been recognized as a rich source of bioactive compounds, including phenolics, that possess important antioxidant, antimicrobial, and antibacterial properties, including activity against drug-resistant bacteria. This study evaluated total phenolic profile and content, total flavonoids content, the antioxidant activities, antimicrobial and antibacterial activities, of water extracts of edible mushrooms from Romanian deciduous forests, including Cantharellus cibarius, Russula virescens, Lactarius piperatus, and Boletus edulis. The extracts were characterized using high-performance liquid chromatography coupled with mass spectrometry (HPLC-MS) and Fourier Transform Infrared Spectroscopy (FTIR) analysis. Antioxidant activity was determined using DPPH radical-scavenging activity and ABTS radical cation decolorization assay. Antimicrobial and antibacterial activities were tested using standard strains of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Enterococcus faecalis, and Streptococcus pneumoniae following diffusion testing and time-killing assay, respectively. The HPLC-MS results indicated that major compounds in all the mushrooms belonged to the subclass of hydroxybenzoic acids. Trans-cinnamic acid and hydroxybenzoic acids, particularly gallic acid, 2,3-dihydroxybenzoic acid, and gentisic acid, were the predominant compounds detected in BEE and CCE. Their concentrations were measured as follows: 24 μg/mL, 63 μg/mL, 56 μg/mL, and 14 μg/mL, respectively, for BEE, and 26 μg/mL, 42 μg/mL, 7 μg/mL, and 5 μg/mL, respectively, for CCE. Among phenolic compounds, 2-dihydroxybenzoic acid, 2,3-dihydroxybenzoic acid, p-anisaldehyde, and gentisic acid were positively correlated with both DPPH (45% and 21% inhibition rate for BEE and CCE, respectively) and ABTS (64 and 31% inhibition rate for BEE and CCE, respectively) antioxidant activities. The FTIR analysis revealed the presence of lipids, proteins, and polysaccharides, extracted in different ratios in the water extract. All mushroom extracts showed a dose-dependent response with higher antimicrobial and antibacterial activities at the highest concentration (26.3 µg phenolics BEE, 12.7 µg pphenolics CCE, 28.3 µg phenolics LPE, and 14.5 µg phenolics RVE per well for antimicrobial activity and 175.2 µg phenolics/mL BEE, 84.4 µg phenolics/mL CCE, and 188.9 µg phenolics/mL LPE for antibacterial activity). These species demonstrate potential for the development of alternative antimicrobial formulations, particularly relevant in the context of antibiotic resistance.

14 March 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
ACAndra Ciocan
Andra Ciocan
RCRazvan Alexandru Ciocan
Razvan Alexandru Ciocan
NHNadim Al Hajjar
Nadim Al Hajjar
ABAndreea M. Benea
Andreea M. Benea
SPStanca-Lucia Pandrea
Stanca-Lucia Pandrea
Sorana D. BolboacăSorana D. Bolboacă
Sorana D. Bolboacă
Chronic inflammation is demonstrated to play a direct role in carcinogenesis. Our exploratory study aimed to assess the potential added value of two inflammation biomarkers, chitotriosidase and neopterin, in follow-up evaluation of patients with colorectal cancer (CRC). An observational exploratory study was conducted. Patients with CRC and matched controls (1:1, age, sex, and living environment) were evaluated. The patients with CRC (CRC group) and controls were assessed at baseline (before surgical intervention for patients with CRC). Patients with CRC were also evaluated at 1-year follow-up. Significantly more patients with blood group A (54.5% vs. 25.0%) and smokers (50.0% vs. 22.7%) were in the CRC group. The serum values of chitotriosidase and neopterin were higher in CRC patients than in controls, but only neopterin reached the conventional level of statistical significance (p-value = 0.015). The circulating chitotriosidase and neopterin values decreased significantly at 1-year follow-up (p-value < 0.0001). Patients with higher N- and M-stage showed statistically significant higher levels of chitotriosidase and neopterin at baseline and 1-year follow-up (p-values < 0.03). Circulating chitotriosidase levels also showed statistically significant differences regarding baseline and 1-year follow-up on patients with CRC and different differentiation grades (p-values < 0.02). The circulating levels of neopterin significantly decreased at 1-year follow-up, indicating its potential as a prognostic marker. The circulating values of chitotriosidase and neopterin exhibit significant differences in patients with than without recurrences. Our results support further evaluation of chitotriosidase and neopterin as prognostic markers in patients with CRC.

19 March 2022 in Journal of Gastrointestinal and Liver Diseases
Verified
Journal Article
Open access
PDF file
PFPetra Fischer
Petra Fischer
SPStanca-Lucia Pandrea
Stanca-Lucia Pandrea
CGCrina Grigoras
Crina Grigoras
HSHoria Stefanescu
Horia Stefanescu
OFOANA FARCAU-NICOARA
OANA FARCAU-NICOARA
DIDaniela Ionescu
Daniela Ionescu
Background and Aims: Bacterial infections are associated with high mortality rates in patients with decompensated cirrhosis. Early diagnosis with the available diagnostic tools is challenging. Metabolomics is a novel technique with a widespread application in hepatology. The aims of our study were to find new biomarkers for decompensated cirrhosis and for those with overlapping bacterial infections. Methods: 43 patients with compensated and 54 patients with decompensated cirrhosis were enrolled in the study. In patients with decompensation, a complete infectious workup was performed at admission. Blood and ascitic fluid were collected and stored at -80° C until performing the metabolomic analysis. Statistical analysis was performed using the Metaboanalyst 4.0 software. Results: 36 patients (66%) in the decompensated group were infected. Among them, 15 had multiple infections; thus, finally, 52 infections were diagnosed. The main metabolic pathways affected in patients with decompensated cirrhosis were those related to lipid metabolism, involving acylcarnitines, stearic acid derivatives, and 12/15 HETE-GABA. N-oleoyl ethanolamine was the most promising biomarker for bacterial infection diagnosis. Moreover, prostaglandin E2/D2/H2 and N-oleoyl alanine levels were higher in Gram- positive infections and ceramides (d16:2/18:0), in Gram-negative infections, respectively. L-phenylalanine (m/z=166.09) and lysophosphatidylethanolamine (18:3/0:0) were the two most relevant identified ascitic biomarkers for spontaneous bacterial peritonitis diagnosis. Conclusions: The lipid and energetic metabolic pathways were the most affected in patients with decompensated cirrhosis and those with overlapping infections.